|
|
|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
| |
Kewaunee Scientific's Long Term Debt to Equity
KEQU's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth
Despite a net increase in long-term borrowings by 0.32%, Kewaunee Scientific managed to enhance Long Term Debt to Equity in the fourth quarter 2025 to 0.36, surpassing the average for Kewaunee Scientific's Long Term Debt to Equity.
Within Laboratory Analytical Instruments industry in the fourth quarter 2025, 2 other companies have achieved lower Long Term Debt to Equity than Kewaunee Scientific in the Q4 2025. While Long Term Debt to Equity total ranking has deteriorated compared to the third quarter 2024 from 814 to 999 .
Explain Long Term Debt to Equity Ratio?
How much Long Term Debts KEQU´s has?
What are KEQU´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
Long Term Debt to Equity ▼
|
Long Term Debt to Equity ▼
|
| KEQU Long Term Debt to Equity |
(Apr 30 2025)
Q4 |
(Jan 31 2025)
Q3 |
(Oct 31 2024)
Q2 |
(Jul 31 2024)
Q1 |
(Apr 30 2024)
Q4 |
| Y / Y Equity Change |
17.85 % |
37.01 % |
39.72 % |
41.87 % |
46.05 % |
| Y / Y Long Term Debt Change |
- |
- |
- |
- |
- |
| Long Term Debt to Equity MRQ |
0.36 |
0.38 |
- |
- |
- |
| KEQU's Total
Ranking |
# 999 |
# 814 |
# 0 |
# 0 |
# 0 |
| Seq. Equity Change |
6.64 % |
2.41 % |
5.47 % |
2.32 % |
23.97 % |
| Seq. Long Term Debt Change |
0.32 % |
- |
- |
- |
- |
| Long Term Debt to Equity fourth quarter 2025 Company Ranking |
| Within: |
No. |
| Laboratory Analytical Instruments Industry |
# 3 |
| Healthcare Sector |
# 117 |
| Overall Market |
# 999 |
| Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 0.38 |
0.1 |
0 |
| (Jan 31 2025) |
|
(Apr 30 2019) |
Cumulative Kewaunee Scientific's Long Term Debt to Equity
KEQU's Long Term Debt to Equity for the trailling 12 Months
KEQU Long Term Debt to Equity |
(Apr 30 2025)
12 Months |
(Jan 31 2025)
12 Months |
(Oct 31 2024)
12 Months |
(Jul 31 2024)
12 Months |
(Apr 30 2024)
12 Months |
| Y / Y Equity TTM Growth |
32.9 % |
40.96 % |
38.38 % |
34.65 % |
27.92 % |
| Y / Y Long Term Debt TTM Growth |
- |
- |
- |
- |
- |
| Long Term Debt to Equity TTM |
0.19 |
0.1 |
- |
- |
- |
| Total Ranking TTM |
# 31
| # 21
|
|
|
|
| Seq. Equity TTM Growth |
4.24 % |
7.64 % |
8.52 % |
9.15 % |
10.56 % |
| Seq. Long Term Debt TTM Growth |
100.32 % |
- |
- |
- |
- |
On the trailing twelve months basis Due to the net new long-term borrowings of 0.32% during the trailing twelve months finishing in the Q4 2025, cumulativeLong Term Debt to Equity improved to 0.19, a new company high. Long Term Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Laboratory Analytical Instruments industry KEQU recorded the lowest Long Term Debt to Equity. While Long Term Debt to Equity total ranking has deteriorated during the twelve months ending in the Q4 2025, compared to the prior period, from 21 to 31.
Explain Long Term Debt to Equity Ratio?
How much Long Term Debts KEQU´s has?
What are KEQU´s Equity?
| TTM Long Term Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Laboratory Analytical Instruments Industry |
# 0 |
| Healthcare Sector |
# 10 |
| Within the Market |
# 31 |
| trailing twelve months Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 0.19 |
0.04 |
0 | | (Apr 30 2025) |
|
(Jan 31 2020) |
| Companies with similar Long Term Debt to Equity in the quarter ending Apr 30 2025, within Laboratory Analytical Instruments Industry | Long Term Debt to Equity | Apr 30 2025 MRQ Long Term Debt | Apr 30 2025 MRQ Equity | | Waters Corporation | 0.69 | $ 1,356.727 Millions | $ 1,962.397 Millions | | Illumina Inc | 0.63 | $ 1,491.000 Millions | $ 2,368.000 Millions | | Agilent Technologies inc | 0.55 | $ 3,349.000 Millions | $ 6,136.000 Millions | | Avantor Inc | 0.54 | $ 3,279.200 Millions | $ 6,098.200 Millions | | Revvity Inc | 0.41 | $ 3,168.384 Millions | $ 7,637.130 Millions | | Kewaunee Scientific Corporation | 0.36 | $ 23.537 Millions | $ 66.245 Millions | | Bio rad Laboratories Inc | 0.18 | $ 1,200.700 Millions | $ 6,679.400 Millions |
|
Date modified: 2025-07-10T19:08:47+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
